Literature DB >> 7881835

Determination of various cytokines and type III procollagen aminopeptide levels in bronchoalveolar lavage fluid of the patients with pulmonary fibrosis: inverse correlation between type III procollagen aminopeptide and interferon-gamma in progressive patients.

S Kuroki1, A Ohta, N Sueoka, O Katoh, H Yamada, M Yamaguchi.   

Abstract

We measured levels of cytokines and type III procollagen aminopeptides (procollagen III peptides) in bronchoalveolar lavage fluid obtained from 20 patients with stable pulmonary fibrosis (PF) and seven patients with progressive PF, and nine control subjects to determine the role of cytokines in the development of PF. Procollagen III peptide levels were markedly increased in progressive PF patients. Tumour necrosis factor-alpha, interleukin-6, transforming growth factor-beta and interferon-gamma (IFN-gamma) levels were elevated in both PF patients as compared with controls, with a tendency of higher levels in progressive patients, whereas interleukin-1 beta (IL-1 beta) level was decreased in both PF patients. When the correlation between procollagen III peptide and various cytokine levels was analysed the only significant correlation was inversely between procollagen III peptide and IFN-gamma in progressive PF patients. These results indicated that although multiple cytokines may be involved in the development of PF, the negative role of IFN-gamma in active collagen synthesis could be also important.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7881835     DOI: 10.1093/rheumatology/34.1.31

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  7 in total

1.  Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-beta in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice.

Authors:  C B Keerthisingam; R G Jenkins; N K Harrison; N A Hernandez-Rodriguez; H Booth; G J Laurent; S L Hart; M L Foster; R J McAnulty
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

Review 2.  The Mechanism and Regulation of the NLRP3 Inflammasome during Fibrosis.

Authors:  Carol M Artlett
Journal:  Biomolecules       Date:  2022-04-26

3.  Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis.

Authors:  William R Coward; Keiria Watts; Carol A Feghali-Bostwick; Alan Knox; Linhua Pang
Journal:  Mol Cell Biol       Date:  2009-06-01       Impact factor: 4.272

Review 4.  The importance of balanced pro-inflammatory and anti-inflammatory mechanisms in diffuse lung disease.

Authors:  Michael P Keane; Robert M Strieter
Journal:  Respir Res       Date:  2001-10-15

5.  The Efficacy and Mechanism Evaluation of Treating Idiopathic Pulmonary fibrosis with the Addition of Co-trimoxazole (EME-TIPAC): study protocol for a randomised controlled trial.

Authors:  Matthew Hammond; Allan B Clark; Anthony P Cahn; Edwin R Chilvers; William Duncan Fraser; David M Livermore; Toby M Maher; Helen Parfrey; Ann Marie Swart; Susan Stirling; David Thickett; Moira Whyte; Andrew Wilson
Journal:  Trials       Date:  2018-02-05       Impact factor: 2.279

Review 6.  Pulmonary fibrosis.

Authors:  David A Zisman; Michael P Keane; John A Belperio; Robert M Strieter; Joseph P Lynch
Journal:  Methods Mol Med       Date:  2005

7.  Analysis of IL-12 p40 subunit gene and IFN-gamma G5644A polymorphisms in Idiopathic Pulmonary Fibrosis.

Authors:  Panagiota Latsi; Panagiotis Pantelidis; Dimitris Vassilakis; Hiroe Sato; Kenneth I Welsh; Roland M du Bois
Journal:  Respir Res       Date:  2003-06-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.